An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea

Study Purpose

The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo in participants with moderate to severe plaque psoriasis in mainland China, Taiwan, and South Korea

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com.

Inclusion Criteria:

  • - Plaque psoriasis for at least 6 months - Moderate to severe disease - Candidate for phototherapy or systemic therapy

    Exclusion Criteria:

    - Other forms of psoriasis - History of recent infection - Prior exposure to BMS-986165 Other inclusion/exclusion criteria may apply.

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04167462
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase 3
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Bristol-Myers Squibb
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Bristol-Myers Squibb
Principal Investigator Affiliation Bristol-Myers Squibb
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Recruiting
Countries China, Korea, Republic of, Taiwan
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Psoriasis
Study Website: View Trial Website
Arms & Interventions

Arms

Experimental: Arm A:BMS-986165 oral administration

Placebo Comparator: Arm B: Placebo oral administration

Interventions

Drug: - BMS-986165

Specified dose on Specified Days

Other: - Placebo

Specified dose on Specified days

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Local Institution, Beijing, Beijing, China

Status

Recruiting

Address

Local Institution

Beijing, Beijing, 100044

Site Contact

Site 0001

[email protected]

please email:

Local Institution, Beijing, Beijing, China

Status

Recruiting

Address

Local Institution

Beijing, Beijing, 100050

Site Contact

Site 0007

[email protected]

please email:

Local Institution, Beijing, Beijing, China

Status

Recruiting

Address

Local Institution

Beijing, Beijing, 100069

Site Contact

Site 0014

[email protected]

please email:

Local Institution, Chongqing, Chongqing, China

Status

Recruiting

Address

Local Institution

Chongqing, Chongqing, 630014

Site Contact

Site 0008

[email protected]

please email:

Local Institution, Wuhan, Hubei, China

Status

Recruiting

Address

Local Institution

Wuhan, Hubei, 430022

Site Contact

Site 0011

[email protected]

please email:

Local Institution, Wuhan, Hubei, China

Status

Recruiting

Address

Local Institution

Wuhan, Hubei, 430030

Site Contact

Site 0016

[email protected]

please email:

Local Institution, Changsha, Hunan, China

Status

Recruiting

Address

Local Institution

Changsha, Hunan, 410011

Site Contact

Site 0013

[email protected]

please email:

Local Institution, Nanjing, Jiangsu, China

Status

Recruiting

Address

Local Institution

Nanjing, Jiangsu, 210029

Site Contact

Site 0005

[email protected]

please email:

Local Institution, Nanjing, Jiangsu, China

Status

Withdrawn

Address

Local Institution

Nanjing, Jiangsu, 210042

Local Institution, Changchun, Jilin, China

Status

Recruiting

Address

Local Institution

Changchun, Jilin, 130021

Site Contact

Site 0002

[email protected]

please email:

Local Institution, Dalian, Liaoning, China

Status

Recruiting

Address

Local Institution

Dalian, Liaoning, 116011

Site Contact

Site 0006

[email protected]

please email:

Local Institution, Taiyuan, Shan1xi, China

Status

Recruiting

Address

Local Institution

Taiyuan, Shan1xi, 030001

Site Contact

Site 0018

[email protected]

please email:

Local Institution, Shanghai, Shanghai, China

Status

Recruiting

Address

Local Institution

Shanghai, Shanghai, SHANGHAI

Site Contact

Site 0012

[email protected]

please email:

Local Institution, Chengdu, Sichuan, China

Status

Recruiting

Address

Local Institution

Chengdu, Sichuan, 610041

Site Contact

Site 0015

[email protected]

please email:

Local Institution, Hangzhou, Zhejiang, China

Status

Recruiting

Address

Local Institution

Hangzhou, Zhejiang, 310003

Site Contact

Site 0009

[email protected]

please email:

Local Institution, Hangzhou, Zhejiang, China

Status

Withdrawn

Address

Local Institution

Hangzhou, Zhejiang, 310009

Local Institution, Hangzhou, Zhejiang, China

Status

Recruiting

Address

Local Institution

Hangzhou, Zhejiang, 310014

Site Contact

Site 0003

[email protected]

please email:

Local Institution, Hangzhou, Zhejiang, China

Status

Recruiting

Address

Local Institution

Hangzhou, Zhejiang, 310016

Site Contact

Site 0004

[email protected]

please email:

Local Institution, Bucheon-si, Korea, Republic of

Status

Recruiting

Address

Local Institution

Bucheon-si, , 14584

Site Contact

Site 0034

[email protected]

please email:

Local Institution, Goyang-si, Korea, Republic of

Status

Recruiting

Address

Local Institution

Goyang-si, , 10380

Site Contact

Site 0033

[email protected]

please email:

Local Institution, Gwangju, Korea, Republic of

Status

Recruiting

Address

Local Institution

Gwangju, , 61469

Site Contact

Site 0028

[email protected]

please email:

Local Institution, Incheon, Korea, Republic of

Status

Recruiting

Address

Local Institution

Incheon, , 21565

Site Contact

Site 0035

[email protected]

please email:

Local Institution, Seongnam-si, Korea, Republic of

Status

Recruiting

Address

Local Institution

Seongnam-si, , 13496

Site Contact

Site 0022

[email protected]

please email:

Local Institution, Seongnam-si, Korea, Republic of

Status

Recruiting

Address

Local Institution

Seongnam-si, , 13620

Site Contact

Site 0037

[email protected]

please email:

Local Institution, Seoul, Korea, Republic of

Status

Recruiting

Address

Local Institution

Seoul, , 02447

Site Contact

Site 0036

[email protected]

please email:

Local Institution, Seoul, Korea, Republic of

Status

Recruiting

Address

Local Institution

Seoul, , 03722

Site Contact

Site 0019

[email protected]

please email:

Local Institution, Seoul, Korea, Republic of

Status

Recruiting

Address

Local Institution

Seoul, , 05030

Site Contact

Site 0021

[email protected]

please email:

Local Institution, Seoul, Korea, Republic of

Status

Recruiting

Address

Local Institution

Seoul, , 06974

Site Contact

Site 0020

[email protected]

please email:

Local Institution, Seoul, Korea, Republic of

Status

Recruiting

Address

Local Institution

Seoul, , 110-774

Site Contact

Site 0026

[email protected]

please email:

Local Institution, Seoul, Korea, Republic of

Status

Recruiting

Address

Local Institution

Seoul, , 137-701

Site Contact

Site 0024

[email protected]

please email:

Local Institution, Seoul, Korea, Republic of

Status

Recruiting

Address

Local Institution

Seoul, , 152-703

Site Contact

Site 0027

[email protected]

please email:

Local Institution, Suwon, Korea, Republic of

Status

Recruiting

Address

Local Institution

Suwon, , 16499

Site Contact

Site 0023

[email protected]

please email:

Local Institution, Kaohsiung, Taiwan

Status

Recruiting

Address

Local Institution

Kaohsiung, , 83301

Site Contact

Site 0029

[email protected]

please email:

Local Institution, Taipei City, Taiwan

Status

Recruiting

Address

Local Institution

Taipei City, , 10048

Site Contact

Site 0031

[email protected]

please email:

Local Institution, Taipei City, Taiwan

Status

Recruiting

Address

Local Institution

Taipei City, , 114

Site Contact

Site 0032

[email protected]

please email:

Local Institution, Taipei, Taiwan

Status

Recruiting

Address

Local Institution

Taipei, , 10590

Site Contact

Site 0025

[email protected]

please email:

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.